Formulation and in vivo evaluation of ocular insert containing phenylephrine and tropicamide

Yung Chi Lee, Jeffrey W. Millard, Gerald J. Negvesky, Salim I. Butrus, Samuel H Yalkowsky

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

A Gelfoam® based ocular device containing 1.7 mg of phenylephrine and 0.6 mg of tropicamide was formulated and evaluated for pupillary dilation in rabbits. The manufacturing procedure is fairly simple and the required excipients are inexpensive. The in vivo results show that the mydriatic response produced by the proposed device is larger and longer lasting than that produced by eyedrops with an equivalent amount of phenylephrine and tropicamide. The results reported in this study, along with those of previous studies, imply that Gelfoam® is a versatile drug carrier for either local or systemic drug delivery via the ophthalmic route. Copyright (C) 1999 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)121-126
Number of pages6
JournalInternational Journal of Pharmaceutics
Volume182
Issue number1
DOIs
StatePublished - May 10 1999

Fingerprint

Tropicamide
Absorbable Gelatin Sponge
Phenylephrine
Mydriatics
Equipment and Supplies
Drug Carriers
Ophthalmic Solutions
Excipients
Dilatation
Rabbits
Pharmaceutical Preparations

Keywords

  • Gelfoam®
  • Mydriasis
  • Mydriatic
  • Ocular device
  • Phenylephrine
  • Tropicamide

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Formulation and in vivo evaluation of ocular insert containing phenylephrine and tropicamide. / Lee, Yung Chi; Millard, Jeffrey W.; J. Negvesky, Gerald; I. Butrus, Salim; Yalkowsky, Samuel H.

In: International Journal of Pharmaceutics, Vol. 182, No. 1, 10.05.1999, p. 121-126.

Research output: Contribution to journalArticle

Lee, Yung Chi ; Millard, Jeffrey W. ; J. Negvesky, Gerald ; I. Butrus, Salim ; Yalkowsky, Samuel H. / Formulation and in vivo evaluation of ocular insert containing phenylephrine and tropicamide. In: International Journal of Pharmaceutics. 1999 ; Vol. 182, No. 1. pp. 121-126.
@article{54b76cc0dcf945bd8ff18527d69f803b,
title = "Formulation and in vivo evaluation of ocular insert containing phenylephrine and tropicamide",
abstract = "A Gelfoam{\circledR} based ocular device containing 1.7 mg of phenylephrine and 0.6 mg of tropicamide was formulated and evaluated for pupillary dilation in rabbits. The manufacturing procedure is fairly simple and the required excipients are inexpensive. The in vivo results show that the mydriatic response produced by the proposed device is larger and longer lasting than that produced by eyedrops with an equivalent amount of phenylephrine and tropicamide. The results reported in this study, along with those of previous studies, imply that Gelfoam{\circledR} is a versatile drug carrier for either local or systemic drug delivery via the ophthalmic route. Copyright (C) 1999 Elsevier Science B.V.",
keywords = "Gelfoam{\circledR}, Mydriasis, Mydriatic, Ocular device, Phenylephrine, Tropicamide",
author = "Lee, {Yung Chi} and Millard, {Jeffrey W.} and {J. Negvesky}, Gerald and {I. Butrus}, Salim and Yalkowsky, {Samuel H}",
year = "1999",
month = "5",
day = "10",
doi = "10.1016/S0378-5173(99)00072-1",
language = "English (US)",
volume = "182",
pages = "121--126",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Formulation and in vivo evaluation of ocular insert containing phenylephrine and tropicamide

AU - Lee, Yung Chi

AU - Millard, Jeffrey W.

AU - J. Negvesky, Gerald

AU - I. Butrus, Salim

AU - Yalkowsky, Samuel H

PY - 1999/5/10

Y1 - 1999/5/10

N2 - A Gelfoam® based ocular device containing 1.7 mg of phenylephrine and 0.6 mg of tropicamide was formulated and evaluated for pupillary dilation in rabbits. The manufacturing procedure is fairly simple and the required excipients are inexpensive. The in vivo results show that the mydriatic response produced by the proposed device is larger and longer lasting than that produced by eyedrops with an equivalent amount of phenylephrine and tropicamide. The results reported in this study, along with those of previous studies, imply that Gelfoam® is a versatile drug carrier for either local or systemic drug delivery via the ophthalmic route. Copyright (C) 1999 Elsevier Science B.V.

AB - A Gelfoam® based ocular device containing 1.7 mg of phenylephrine and 0.6 mg of tropicamide was formulated and evaluated for pupillary dilation in rabbits. The manufacturing procedure is fairly simple and the required excipients are inexpensive. The in vivo results show that the mydriatic response produced by the proposed device is larger and longer lasting than that produced by eyedrops with an equivalent amount of phenylephrine and tropicamide. The results reported in this study, along with those of previous studies, imply that Gelfoam® is a versatile drug carrier for either local or systemic drug delivery via the ophthalmic route. Copyright (C) 1999 Elsevier Science B.V.

KW - Gelfoam®

KW - Mydriasis

KW - Mydriatic

KW - Ocular device

KW - Phenylephrine

KW - Tropicamide

UR - http://www.scopus.com/inward/record.url?scp=0032945790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032945790&partnerID=8YFLogxK

U2 - 10.1016/S0378-5173(99)00072-1

DO - 10.1016/S0378-5173(99)00072-1

M3 - Article

C2 - 10332081

AN - SCOPUS:0032945790

VL - 182

SP - 121

EP - 126

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1

ER -